Using Insights into Pim1 Structure to Design New Anticancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3964-3978

Bentham Science Publishers

Access to resources Recommend Favorite

Nonpeptidic Chymase Inhibitors: Design and Structure-Activity Relationships of Pyrimidinone Derivatives Based on the Predicted Binding Mode of a Peptidic Inhibitor

By  

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1191-1199

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based HIV-1 integrase inhibitor design: a future perspective

By Neamati N.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 281-296

Informa Healthcare

Access to resources Recommend Favorite

Structure-Based Inhibitor Design Targeting HIV-1 Integrase

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 3, 2002-09 ,pp. : 217-234

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 7, 2010-05 ,pp. : 696-707

Bentham Science Publishers

Access to resources Recommend Favorite